Active GLP-1 was identified in pancreatic perfusate from Gcgr -/- but not wild-type mice (27), and FGF21 acts additively with GLP-1 to prevent insulinopenic diabetes in mice lacking glucagon action (28), which further reduces the risk of Gcgr -/- mice developing diabetes. Here, GCGR is linked to diabetes mellitus.